NEW YORK, Jan. 24, 2024 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for KURA, PATH, AI, CRWD, and RDHL.

InvestorsObserver (PRNewsfoto/InvestorsObserver)

To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.

  1. KURA: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=KURA&prnumber=202401240
  2. PATH: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=PATH&prnumber=202401240
  3. AI: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=AI&prnumber=202401240
  4. CRWD: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=CRWD&prnumber=202401240
  5. RDHL: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=RDHL&prnumber=202401240

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.

InvestorsObserver provides patented technology to some of the biggest names on Wall Street and creates world-class investing tools for the self-directed investor on Main Street. We have a wide range of tools to help investors make smarter decisions when investing in stocks or options.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-kura-oncology-uipath-c3ai-crowdstrike-or-redhill-biopharma-302043328.html

SOURCE InvestorsObserver